logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8865641 B1

PDFFull Text
Date of Patent:
Oct. 21, 2014

Filed:

Jun. 14, 2012

Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways

Applicants:

Valentin A. Pavlov, Bayside, NY (US);

Kevin J. Tracey, Old Greenwich, CT (US);

Inventors:

Valentin A. Pavlov, Bayside, NY (US);

Kevin J. Tracey, Old Greenwich, CT (US);

Assignee:

The Feinstein Institute for Medical Research, Manhasset, NY (US);

Attorney:

Hamilton, Brook, Smith & Reynolds, PC.

Primary Examiner:

Maury Audet

Assistant Examiner:

Zachary J Miknis

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A01N 43/00 (2006.01); A01N 43/46 (2006.01); A61K 31/55 (2006.01); A01N 43/62 (2006.01); A61K 31/4965 (2006.01); A01N 43/42 (2006.01); A61K 31/44 (2006.01); A01N 43/90 (2006.01); A01N 43/40 (2006.01); A61K 31/425 (2006.01); A01N 43/08 (2006.01); A61K 31/34 (2006.01); A01N 47/10 (2006.01); A61K 31/27 (2006.01); A01N 37/18 (2006.01); A61K 31/16 (2006.01); A01N 33/12 (2006.01); A61K 31/14 (2006.01); A61K 31/444 (2006.01); A61K 31/495 (2006.01); A61K 31/341 (2006.01); A61K 31/4545 (2006.01); A61K 31/46 (2006.01); A61K 31/5513 (2006.01); A61K 31/167 (2006.01); A61K 31/439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/14 (2013.01); A61K 31/444 (2013.01); A61K 31/495 (2013.01); A61K 31/55 (2013.01); A61K 31/341 (2013.01); A61K 31/27 (2013.01); A61K 31/4545 (2013.01); A61K 31/46 (2013.01); A61K 31/5513 (2013.01); A61K 31/167 (2013.01); A61K 31/439 (2013.01);
Abstract

A method of treating a fatty liver disease in a subject. The method comprises administering to the subject an effective amount of a cholinergic pathway stimulating agent, wherein the fatty liver disease is selected from non-alcoholic fatty liver (NAFL), alcoholic fatty liver (AFL), non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), NASH-associated liver fibrosis, ASH-associated liver fibrosis, non-alcoholic cirrhosis, and alcoholic cirrhosis.

Find Patent Forward Citations

Pavlov, Valentin. (2014). Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways (U.S. Patent No. 8865641). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8865641

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…